Exceeding Industry's expectations in the North East
The length of time it takes to get a study up and running is crucial to commercial research. Delays cost money. So when the County Durham and Tees Valley Comprehensive Local Research Network (CLRN) obtained approval from South Tees Hospitals NHS Foundation Trust for a commercial cardiovascular study within two days of receiving the relevant paperwork, it was a real accomplishment.
Read the feature article (85kb)
Biopharma benefit
A Roche study into the use of a biopharmaceutical treatment for early-diagnosis rheumatoid arthritis took just forty-four days to obtain NHS R&D permission – and has been well received by NHS patients.
Read the feature article (345kb)
Primary Care Research Network steps into the breach
Network turns around UK recruitment on Servier's global CLARIFY study
Coronary Artery Disease (CAD) is the UK’s biggest killer and the leading cause of death worldwide. Servier, the leading French independent pharmaceutical company, recently set out to recruit 2000 patients in the UK as part of a global study to increase the knowledge and understanding of the disease. When the study looked like it wasn’t going to make its recruitment target, the Primary Care Research Network (PCRN) stepped into the breach.
Read the feature article (full story 166kb)
Watch a video of Servier's National Cardiology Medical Liaison Manager describing the support he received from the Primary Care Research Network.
